These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 8838932

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
    Chua SH, Goh CL, Ang CB.
    Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
    [Abstract] [Full Text] [Related]

  • 4. Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients.
    Orecchia G, Malagoli P, Santagostino L.
    Pediatr Dermatol; 1994 Mar; 11(1):65-8. PubMed ID: 8170854
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Squaric acid sensitization is not required for response in the treatment of alopecia areata.
    Vedak P, Kroshinsky D.
    J Am Acad Dermatol; 2015 Sep; 73(3):471-6. PubMed ID: 26282797
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Squaric acid dibutyl ester in the treatment of alopecia areata.
    Barth JH, Darley CR, Gibson JR.
    Dermatologica; 1985 Sep; 170(1):40-2. PubMed ID: 3882480
    [Abstract] [Full Text] [Related]

  • 12. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
    Morita K, Nakamura M, Nagamachi M, Kishi T, Miyachi Y.
    J Dermatol; 2002 Oct; 29(10):661-4. PubMed ID: 12433000
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic approach with squaric acid dibutylester for steroid resistant-alopecia areata incognita: A pilot study of a single center.
    Starace M, Vezzoni R, Alessandrini A, Bruni F, Carpanese MA, Misciali C, Sechi A, Piraccini BM.
    Dermatol Ther; 2021 Sep; 34(5):e15096. PubMed ID: 34390608
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S, Freyschmidt-Paul P, Hoffmann R, Sundberg JP, Happle R, Lindsey NJ, Tobin DJ.
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [Abstract] [Full Text] [Related]

  • 17. Immunohistological evaluation of alopecia areata treated with squaric acid dibutylester (SADBE).
    Johansson E, Ranki A, Reunala T, Kianto U, Niemi KM.
    Acta Derm Venereol; 1986 Aug; 66(6):485-90. PubMed ID: 2433867
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evaluation.
    Losol E, Şentürk N.
    Dermatol Ther; 2021 Jan; 34(1):e14726. PubMed ID: 33377267
    [Abstract] [Full Text] [Related]

  • 20. Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial.
    Dall'oglio F, Nasca MR, Musumeci ML, La Torre G, Ricciardi G, Potenza C, Micali G.
    J Dermatolog Treat; 2005 Feb; 16(1):10-4. PubMed ID: 15897160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.